Home
Conditions
Stage IV Squamous Cell Carcinoma of the Nasopharynx

Clinical trial condition

Stage IV Squamous Cell Carcinoma of the Nasopharynx

Explore clinical trials studying Stage IV Squamous Cell Carcinoma of the Nasopharynx. Study availability and eligibility vary by location and protocol.

33 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Stage IV Squamous Cell Carcinoma of the Nasopharynx trial results

Completed

Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer

NCT00454142

Conditions: Recurrent Lymphoepithelioma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Stage IV Lymphoepithelioma of the Nasopharynx, +1 more
Locations: Cancer Therapeutics Research Group Singapore

National University Hospital Singapore

National Cancer Centre Singapore

View Trial Details

Completed

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

NCT00397384

Conditions: Adenocarcinoma, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, +135 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

NCT00114283

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +46 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00507767

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +48 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

NCT00387335

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +19 more
Locations: University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

NCT00101348

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +122 more
Locations: Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States

View Trial Details

Completed

Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

NCT00049283

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +37 more
Locations: Case Western Reserve University Cleveland, Ohio, United States

View Trial Details

Completed

Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT00103259

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +35 more
Locations: Eastern Cooperative Oncology Group Boston, Massachusetts, United States

View Trial Details

Completed

Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer

NCT00492089

Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Meningioma, +126 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00513435

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +49 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Stage IV Squamous Cell Carcinoma of the Nasopharynx

Stage IV Squamous Cell Carcinoma of the Nasopharynx trial results

Related conditions